Focus on Experienced Anxiety Related to an Emergency Department Visit (FEAR-ED)

March 12, 2024 updated by: Medical Centre Leeuwarden
The aim of the present study is to determine the prevalence of anxiety in adult patients attending the ED of the Medical Centre Leeuwarden.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Determination of the prevalence of anxiety in adult patients attending the ED of the Medical Centre Leeuwarden. Secondarily, the common causes of anxiety and the effect of anxiety on the time of presentation to the ED and perceived pain will be investigated. In addition to gaining more insight into the relationship between the ED and anxiety, the study aims to raise awareness of anxiety among patients in the ED.

Study Type

Observational

Enrollment (Actual)

139

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Netherlands
    • Friesland
      • Leeuwarden, Friesland, Netherlands, 8934 AD
        • MCLeeuwarden

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patients visiting the ED.

Description

Inclusion Criteria:

  • Age 18 years and older
  • Competent to decide on study participation
  • Written informed consent obtained

Exclusion Criteria:

  • Patients from who a Dutch questionnaire cannot be obtained (e.g. delirious, comatose, confused and non-Dutch speaking patients)
  • If the reason for ED presentation is: suicide, intoxication or reporting from a sexual violence center
  • Patients with an active eating disorder
  • Patient already included in this study
  • Objection to the use of patient data registered in the EPD

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of anxiety measured by GAD-7 and VAS-A
Time Frame: Two weeks prior to ED presentation
What is the prevalence of anxiety among adult patients in the ED?
Two weeks prior to ED presentation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Timing ER visit
Time Frame: 1 Day
What influence does fear have on the timing of the ER visit?
1 Day
Start of fear (open question)
Time Frame: 1 Day
What was the moment when fear arised?
1 Day
Influence of pain (NRS) on fear (GAD-7)
Time Frame: 1 Day
What is the influence of pain on fear experienced?
1 Day
Cause of fear (open question)
Time Frame: 1 Day
What is the cause of fear?
1 Day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Medical Centre Leeuwarden

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 8, 2023

Primary Completion (Actual)

December 11, 2023

Study Completion (Actual)

December 11, 2023

Study Registration Dates

First Submitted

December 15, 2023

First Submitted That Met QC Criteria

January 1, 2024

First Posted (Actual)

January 11, 2024

Study Record Updates

Last Update Posted (Actual)

March 13, 2024

Last Update Submitted That Met QC Criteria

March 12, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MCLSEH1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fear

Clinical Trials on Questionnaire

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe